Short-Term Efficacy of Enzyme Replacement Therapy in Korean Patients with Fabry Disease

Fabrazyme has been widely used for treatment of Fabry disease since its approval by the U.S. Food and Drug Administration in 2003. This study was undertaken to assess the short-term efficacy and safety of enzyme replacement therapy (ERT) for Fabry disease in Korea. Eight male patients and three fema...

Full description

Saved in:
Bibliographic Details
Main Authors: Choi, Jin-Ho, Cho, Young Mi, Suh, Kwang-Sun, Yoon, Hye-Ran, Kim, Gu-Hwan, Kim, Sung-Su, Ko, Jung Min, Lee, Joo Hoon, Park, Young Seo, Yoo, Han-Wook
Format: Artigo
Language:Inglês
Published: The Korean Academy of Medical Sciences 2008
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2526436/
https://ncbi.nlm.nih.gov/pubmed/18437007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2008.23.2.243
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items